| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/10/2023 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 17.3% stake in Adaptimmune Therapeutics PLC |
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/03/2022 |
3
| Matrix Capital Management Company, LP (10% Owner) has filed a Form 3 on Zentalis Pharmaceuticals, Inc. |
| 06/03/2022 |
SC 13D
| Matrix Capital Management Company, LP reports a 16.4% stake in Zentalis Pharmaceuticals, Inc. |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/18/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 16.9% stake in Altair Engineering, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 9.6% stake in Zentalis Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G
| Matrix Capital Management Company, LP reports a 7.7% stake in Perimeter Solutions, SA |
| 02/14/2022 |
SC 13G
| Matrix Capital Management Company, LP reports a 7.9% stake in ForgeRock, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Matrix Capital Management Company, LP reports a 0% stake in BigCommerce Holdings, Inc. |
| 11/04/2021 |
SC 13D
| Matrix Capital Management Company, LP reports a 14.5% stake in Aura Biosciences, Inc. |
| 11/04/2021 |
4
| Matrix Capital Management Company, LP (10% Owner) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Converted 2,327,870 shares
@ $0
Bought 1,785,000 shares
@ $14, valued at
$25M
Converted 2,327,870 convertible preferred
@ $0 |
|
| 10/28/2021 |
3
| Matrix Capital Management Company, LP (10% Owner) has filed a Form 3 on Aura Biosciences, Inc. |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G
| Matrix Capital Management Company, LP reports a 9.4% stake in Zentalis Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G
| Matrix Capital Management Company, LP reports a 5.3% stake in BigCommerce Holdings, Inc. |
|